Dare Bioscience, Inc. (DARE): Operating Cash Flow
-$9.90M
Year ended 2025-12-31
-$11.30M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.90M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $5.40M | n/m | 2025-03-31, From 2024-01-01 |
| 2023-12-31 | -$38.90M | n/m | 2024-03-28, From 2023-01-01 |
| 2022-12-31 | -$18.10M | n/m | 2023-03-30, From 2022-01-01 |
| 2021-12-31 | -$28.80M | n/m | 2022-03-31, From 2021-01-01 |
| 2020-12-31 | -$25.20M | n/m | 2021-03-30, From 2020-01-01 |
| 2019-12-31 | -$13.30M | n/m | 2020-03-27, From 2019-01-01 |
| 2018-12-31 | -$10.30M | n/m | 2019-04-01, From 2018-01-01 |
| 2017-12-31 | -$2.54M | n/m | 2018-03-28, From 2017-01-01 |
| 2016-12-31 | -$372.3K | n/m | 2018-03-28, From 2016-01-01 |
| 2015-12-31 | -$31.91M | n/m | 2017-06-13, From 2015-01-01 |
| 2014-12-31 | -$19.06M | n/m | 2017-06-13, From 2014-01-01 |
| 2013-12-31 | -$16.61M | n/m | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | -$21.00M | n/a | 2015-03-19, From 2012-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$9.90M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$6.85M | n/m |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | -$39.88M | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$289.8K | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$4.02M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$18.92M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$12.35M | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$18.64M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | -$29.81M | n/m |
Compare DARE, SXTP, STTK, BSPK side by side · Screen every company in Pharmaceutical Preparations ↗